​

Viridian Therapeutics Ownership | Who Owns Viridian Therapeutics?

OverviewForecastRevenueFinancialsChart

Viridian Therapeutics Ownership Summary

Viridian Therapeutics is owned by 115.89% institutional investors, 0.16% insiders. Fmr is the largest institutional shareholder, holding 17.89% of VRDN shares. Fidelity Select Health Care is the top mutual fund, with 3.22% of its assets in Viridian Therapeutics shares.

VRDN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockViridian Therapeutics115.89%0.16%-16.05%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.88M17.89%$227.78M
Blackrock4.77M7.81%$62.10M
Vanguard group4.60M6.92%$88.09M
Blackrock funding, inc. /de5.52M6.77%$77.18M
Deep track capital, lp5.38M6.59%$75.22M
Kynam capital management, lp4.43M5.43%$61.90M
Vr adviser3.88M4.76%$54.28M
State street2.77M4.54%$36.07M
Fairmount funds management3.46M4.24%$48.37M
Commodore capital lp2.40M3.61%$46.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp4.43M6.66%$61.90M
Fairmount funds management3.46M6.27%$48.37M
Vr adviser3.88M4.07%$54.28M
Commodore capital lp2.40M3.37%$46.01M
5am venture management736.60K3.37%$14.12M
Kopp family office205.41K2.50%$3.94M
Highvista strategies484.56K2.49%$6.77M
Eversept partners, lp1.90M2.45%$26.60M
Deep track capital, lp5.38M2.41%$75.22M
Ghost tree capital587.71K2.39%$7.65M

Top Buyers

HolderShares% AssetsChange
Baker bros. advisors lp1.74M0.24%1.74M
Price t rowe associates inc /md/1.33M0.00%1.28M
Blackrock4.77M0.00%960.99K
Fmr11.88M0.01%698.43K
Eversept partners, lp1.90M2.45%524.87K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---1.96M
State street2.77M0.00%-1.72M
Paradigm biocapital advisors lp1.82M1.21%-1.08M
Driehaus capital management376.85K0.04%-893.63K
Polar capital---889.20K

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp1.74M0.24%1.74M$24.39M
Victory capital management410.44K0.01%410.44K$7.87M
Bnp paribas arbitrage, snc203.85K0.00%203.85K$3.91M
Hudson bay capital management lp119.56K0.01%119.56K$1.67M
Vestal point capital, lp100.00K0.07%100.00K$1.40M

Sold Out

HolderChange
True wealth design-4.00
Larson financial group-8.00
Nelson, van denburg & campbell wealth management group-8.00
Parallel advisors-10.00
Creative financial designs inc /adv-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025174-1.69%94,556,3498.58%1151.01%87-6.45%6416.36%
Mar 31, 2025179-6.28%91,344,3270.33%1120.60%92-24.59%5534.15%
Dec 31, 20241866.29%85,180,374-2.05%1280.75%1187.27%40-4.76%
Sep 30, 202417318.49%86,676,79324.72%1301.01%11124.72%4037.93%
Jun 30, 20241462.10%69,497,343-1.95%1130.85%892.30%29-12.12%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Health Care2.63M3.22%1.66K
Vanguard US Total Market Shares ETF2.24M2.75%324.50K
Vanguard Total Stock Mkt Idx Inv2.24M2.74%-49.64K
Fidelity Advisor Biotechnology I1.75M2.14%400.00
iShares Russell 2000 ETF1.64M2.01%-31.08K
Fidelity Advisor Health Care I1.54M1.89%-
US Small-Cap Growth II Equity Comp1.21M1.48%237.23K
T. Rowe Price New Horizons1.21M1.48%-6.02K
Fidelity Small Cap Growth1.05M1.29%-
FIAM Small Cap Core Composite1.01M1.24%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 27, 2024Beetham Thomas W. Chief Operating OfficerBuy$117.05K
Sep 27, 2024Mahoney Stephen F. President and CEOBuy$499.26K
Sep 13, 2024Fairmount Funds Management LLC Buy$30.00M
Jan 22, 2024Fairmount Funds Management LLC See RemarksBuy$10.00M
Jun 16, 2023Meisner Lara Chief Legal OfficerSell$765.45

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q33-
2024 Q2--

VRDN Ownership FAQ

Who Owns Viridian Therapeutics?

Viridian Therapeutics shareholders are primarily institutional investors at 115.89%, followed by 0.16% insiders and -16.05% retail investors. The average institutional ownership in Viridian Therapeutics's industry, Biotech Stocks , is 306.59%, which Viridian Therapeutics falls below.

Who owns the most shares of Viridian Therapeutics?

Viridian Therapeutics’s largest shareholders are Fmr (11.88M shares, 17.89%), Blackrock (4.77M shares, 7.81%), and Vanguard group (4.6M shares, 6.92%). Together, they hold 32.62% of Viridian Therapeutics’s total shares outstanding.

Does Blackrock own Viridian Therapeutics?

Yes, BlackRock owns 7.81% of Viridian Therapeutics, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.1M$. In the last quarter, BlackRock increased its holdings by 960.99K shares, a 25.21% change.

Who is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.66% of its assets in 4.43M Viridian Therapeutics shares, valued at 61.9M$.

Who is the top mutual fund holder of Viridian Therapeutics shares?

Fidelity Select Health Care is the top mutual fund holder of Viridian Therapeutics shares, with 3.22% of its total shares outstanding invested in 2.63M Viridian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools